Paradigm Biocapital Advisors LP
- SEC CIK
- 0001855655
- Latest filing
- Aug 14, 2026
LENZ holding history
LENZ Therapeutics, Inc. in every 13F filed by Paradigm Biocapital Advisors LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
LENZ overviewAll 13F holders of LENZFull Q2 2026 holdings
- Shares (Q4 2025)
- 0
- Sold out in Q4 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 4
- Since Q4 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2025 | 0 | $0 | 0.0% | −1,073,461−100.0% | Sold out | Holders |
| Q3 2025 | 1,073,461 | $50.0M | 1.5% | −643,605−37.5% | Reduced | Holders |
| Q2 2025 | 1,717,066 | $50.3M | 2.1% | +205,134+13.6% | Added | Holders |
| Q1 2025 | 1,511,932 | $38.9M | 1.8% | +741,477+96.2% | Added | Holders |
| Q4 2024 | 770,455 | $22.2M | 0.8% | +770,455 | New | Holders |